A detailed history of Montanaro Asset Management LTD transactions in Bio Techne Corp stock. As of the latest transaction made, Montanaro Asset Management LTD holds 302,300 shares of TECH stock, worth $21.6 Million. This represents 3.84% of its overall portfolio holdings.

Number of Shares
302,300
Previous 365,300 17.25%
Holding current value
$21.6 Million
Previous $28.2 Million 24.51%
% of portfolio
3.84%
Previous 5.3%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$65.98 - $77.09 $4.16 Million - $4.86 Million
-63,000 Reduced 17.25%
302,300 $21.3 Million
Q4 2023

Feb 09, 2024

SELL
$52.83 - $78.22 $2.3 Million - $3.4 Million
-43,500 Reduced 10.64%
365,300 $28.2 Million
Q3 2023

Nov 13, 2023

BUY
$67.52 - $89.42 $1.35 Million - $1.79 Million
20,000 Added 5.14%
408,800 $27.8 Million
Q2 2023

Aug 11, 2023

BUY
$73.76 - $85.98 $73,760 - $85,980
1,000 Added 0.26%
388,800 $31.7 Million
Q4 2022

Feb 08, 2023

BUY
$80.67 - $352.29 $23.1 Million - $101 Million
285,850 Added 280.38%
387,800 $32.1 Million
Q3 2022

Nov 09, 2022

BUY
$282.54 - $391.85 $2.26 Million - $3.13 Million
8,000 Added 8.52%
101,950 $29 Million
Q2 2022

Aug 05, 2022

BUY
$322.67 - $449.65 $1.29 Million - $1.8 Million
4,000 Added 4.45%
93,950 $32.6 Million
Q1 2022

May 12, 2022

SELL
$353.85 - $487.79 $5.13 Million - $7.07 Million
-14,500 Reduced 13.88%
89,950 $39 Million
Q4 2021

Feb 11, 2022

BUY
$456.15 - $525.06 $5.02 Million - $5.78 Million
11,000 Added 11.77%
104,450 $54 Million
Q3 2021

Nov 15, 2021

BUY
$444.87 - $538.88 $5.62 Million - $6.8 Million
12,625 Added 15.62%
93,450 $45.3 Million
Q2 2021

Aug 13, 2021

BUY
$387.35 - $450.26 $1.4 Million - $1.63 Million
3,625 Added 4.7%
80,825 $36.4 Million
Q1 2021

May 12, 2021

BUY
$314.62 - $411.0 $24.3 Million - $31.7 Million
77,200 New
77,200 $29.5 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Montanaro Asset Management LTD Portfolio

Follow Montanaro Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montanaro Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Montanaro Asset Management LTD with notifications on news.